| 7917 |
ZACROS Corporation
|
Earnings |
|
Supplementary Explanation Materials for the Third Quarter of Fiscal Year Ending March 2026
|
Feb 5, 2026
|
| 7917 |
ZACROS Corporation
|
Earnings |
|
Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 7609 |
Daitron Corporation
|
Dividend |
|
Notice Regarding Dividend of Surplus
|
Feb 5, 2026
|
| 7609 |
Daitron Co., Ltd.
|
Other |
|
Notice Regarding the Summary of the Effectiveness Evaluation Results of the Company’s Board of Directors
|
Feb 5, 2026
|
| 7609 |
Daitron Co., Ltd.
|
Earnings |
|
Fiscal Year Ending December 2025 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 7259 |
Aisin Corporation
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Feb 5, 2026
|
| 6458 |
Sankyo Co., Ltd.
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition
(Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Feb 5, 2026
|
| 6088 |
SIGMAXYZ Inc.
|
Earnings |
|
Supplementary Financial Materials Q3 FY2026
|
Feb 5, 2026
|
| 6088 |
SIGMAXYZ Inc.
|
Earnings |
|
Fiscal Year Ending March 2026, 3rd Quarter Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 5208 |
Arisawa Manufacturing Co., Ltd.
|
Strategy |
|
Notice Regarding Establishment of Overseas Subsidiary, Capital Increase of Existing Subsidiary (Grandchild Company), and Changes to Specified Subsidiary
|
Feb 5, 2026
|
| 5208 |
Arisawa Manufacturing Co., Ltd.
|
Earnings |
|
Notice Regarding Revision of Full-Year Consolidated Earnings Guidance and Dividend Forecast
|
Feb 5, 2026
|
| 5208 |
Arisawa Manufacturing Co., Ltd.
|
Earnings |
|
Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 4559 |
Zeria Pharmaceutical Co., Ltd.
|
Share Buyback |
|
Notice Regarding Cancellation of Treasury Stock
|
Feb 5, 2026
|
| 4559 |
Zeria Pharmaceutical Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 3636 |
Mitsubishi Research Institute, Inc.
|
Earnings |
|
Financial Summary for Q1 of Fiscal Year Ending September 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 3046 |
JINS Holdings Inc.
|
Earnings |
|
Monthly Sales Status for January 2026 (Fiscal Year Ending August 2026) (Preliminary) and Related Information
|
Feb 5, 2026
|
| 2317 |
Systena Corporation
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 2001 |
Nippn Corporation
|
Earnings |
|
Fiscal Year Ending March 2026, 3rd Quarter Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
| 2001 |
Nippn Corporation
|
Earnings |
|
Consolidated Cumulative Results for the Third Quarter and Full-Year Consolidated Earnings Forecast
|
Feb 5, 2026
|
| 1926 |
Light Industry Co., Ltd.
|
Earnings |
|
Financial Summary for the 3rd Quarter of Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
|
Feb 5, 2026
|
